國家衛生研究院 NHRI:Item 3990099045/4593
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 912682      線上人數 : 1183
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4593


    題名: New-onset diabetes mellitus associated with use of atypical antipsychotics among schizophrenic patients in Taiwan
    作者: Cheng, JS;Huang, WF;Tsai, YW;Lin, KM;Shih, YT
    貢獻者: Division of Health Policy Research and Development;Division of Mental Health and Addiction Medicine
    摘要: OBJECTIVES: Atypical antipsychotic-induced diabetes has raised concerns recently, while the extent of a typical antipsychotic-induced diabetes mellitus among Asians with schizophrenia is not well known. This study aims to compare the association of atypical antipsychotic treatments and diabetes mellitus with that of haloperidol treatment and diabetes mellitus among schizophrenic patients in Taiwan. METHODS: Data used in this study came from Taiwan’s National Health Insurance claims database for the period 2000–2004. This study identified antipsychotic treatment episodes of clozapine, olanzapine,risperidone, quetiapine, amisulpride, ziprasidone, and haloperidol. Inclusion criteria of treatment episodes were that the subjectswere aged 18 years or above, had had at least one admission due to schizophrenia during the two-year period prior to the initiation of the treatment episodes, and with no diabetes mellitus during a one-year period prior to the initiation of the treatment episodes. Diabetes mellitus was identified by claims with such diagnosis or with antidiabetic agents. A logistic regression model was applied to evaluate the likelihood of newly-on set cases of diabetes of different antipsychotic treatment episodes. Patient and clinical characteristics were included as covariates. RESULTS: Compared with users of haloperidol, those receiving clozapine, olanzapine, and risperidone had a higher probability of developing diabetes mellitus. Those taking quetiapine, amisulpride,and ziprasidone, however, had no significantly higher odds of developing diabetes mellitus. CONCLUSIONS: The preliminary findings of this study support reports of atypical antipsychotics-induced diabetes mellitus. Clozapine, olanzapine,and risperidone, compared with haloperidol, are associated with an increased risk of diabetes mellitus among schizophrenic patients in Taiwan.
    日期: 2006-05
    關聯: Value in Health. 2006 May-Jun;9(3):A65-A66.
    Link to: http://dx.doi.org/10.1016/S1098-3015(10)64507-X
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1098-3015&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000237224200204
    顯示於類別:[林克明(2004-2009)] 會議論文/會議摘要
    [蔡憶文(1999-2010)] 會議論文/會議摘要
    [石曜堂(1999-2006)] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000237224200204.pdf62KbAdobe PDF619檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋